If we cure all diseases (all diseases, that is, except aging itself) 20% will make it to 95. So if you’re part of that lucky 1 in 5, curing all disease would give you only 10 years more than you would have had in 1960.
The graph assumes that we don’t ever get any better at avoiding accidents or violent incident – but at least 80% of us would make it to age 250. 20% would live 1000 years or more.
The de Grey/ Phoenix model predicts that, if progress in eliminating successive types of damage continues at a sufficient pace (which, we stress, is a pace very typical of past technologies – prominent examples include powered flight, computers and the combating of infectious diseases), the amount of damage present in the body can be kept low, with a negligible rate of age-related death per year, irrespective of a person’s age.
Your Chances for Extreme Longevity Depend Age when the First in a Series of Rejuvenation Treatments Arrive
How long could you live and the odds depend on when major rejuvenation technology starts.
If you are 50 when SENS 1.0 arrives then you have better than even odds of living hundreds of years.
If you are 70 when SENS 1.0 arrives then you 10% chance of living hundreds of years.
If you are 80 when SENS 1.0 arrives then most likely you might a few extra years and then die as the current normal situation.
The gap between better aging treatments and the quality of the treatments also is a factor. The above graph assumes aging mechanisms are halved every 40 years. If the aging mechanisms are halved at a faster pace then more people will live longer. If aging mechanisms are more than halved then more people will live. If the treatments are less effective and take longer to develop then more people will die.
Aubrey de Grey think there’s a 50% chance of getting the first-generation SENS [life extension] therapies working within 25-30 years.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.